By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ferring Pharmaceuticals 

Avenue de Rhodanie 60

Lausanne    CH 1007  Switzerland
Phone: 41-21-614-2772 Fax: 41-21-614-2773


SEARCH JOBS


Industry
Pharmaceutical






Company News
Ferring Pharmaceuticals Announces European Approval Of New Room Temperature Stable Formulation Of PABAL (Carbetocin) 4/7/2015 10:34:58 AM
Ferring Pharmaceuticals Receives FDA Approval For Growth Hormone Name Change, Acquires ZOMACTON [Somatropin (rDNA Origin)] For Injection And Needle-Free Device In The U.S. 3/31/2015 6:22:30 AM
Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc. 2/23/2015 12:12:04 PM
Ferring Pharmaceuticals Announces European Launch Of CORTIMENT MMX (Budesonide) For Ulcerative Colitis, And New Data Re-Confirms Safety And Efficacy 2/20/2015 8:57:42 AM
Ferring Pharmaceuticals Acquires Two Phase III Ready Orthobiologic Product Candidates From BioSET 2/19/2015 10:47:30 AM
Family That Overcame Infertility Awarded Educational Grant As Winner Of Ferring Pharmaceuticals' 2014 Heart To Heart Video Contest 2/11/2015 3:13:41 PM
Ferring Pharmaceuticals Moves To Strengthen Growth With Appointment Of Chief Medical And Chief Scientific Officers 1/27/2015 11:12:23 AM
Ferring Pharmaceuticals Opens New U.S. Operations Center With Plans For Significant Job Growth In New Jersey 12/5/2014 7:05:23 AM
Ferring Pharmaceuticals Release: New Data From A Pooled Analysis Shows Improved Overall Survival For Prostate Cancer Patients Treated With FIRMAGON® (Degarelix) Compared To LHRH Agonists 11/25/2014 10:04:28 AM
Ferring Pharmaceuticals: CORTIMENT® MMX®, A New Treatment For Ulcerative Colitis, Receives European Approval 10/22/2014 10:50:42 AM
12345678910...
//-->